TITLE

Olmesartan label to warn of sprue-like side effects

PUB. DATE
July 2013
SOURCE
Reactions Weekly;7/13/2013, Issue 1461, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the labels for the antihypertensive olmesartan medoxomil which are to be updated by the U.S. Food and Durgs Administration (FDA) to warn the risk of sprue-like enteropathy.
ACCESSION #
89151165

 

Related Articles

  • FDA approves Exforge HCT for treatment of hypertension.  // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p59 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to the antihypertensive drug Exforge HCT for patients with moderate-to-severe hypertension.

  • FDA proposes new drug guides for consumers.  // HealthFacts;Oct95, Vol. 20 Issue 197, p2 

    Reports that the Food and Drug Administration (FDA) is proposing a new standard for drug guides for consumers. Flaws of the plan as including inability of the FDA to meet their own standards; Medication guide for the antibiotic Ceclor as FDA's prototype.

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;3/15/2003, Vol. 60 Issue 6, p544 

    Focuses on the changes made in the labeling approved by the U.S. Food & Drug Administration. Changes made in the brand of Estradiol; Benefits of Paroxetine hydrochloride; Warning added to the Sirolimus oral solution and tablets.

  • Standardized over-the-counter labels are not all-over-the-map. Greenberg, Eric F. // Packaging Digest;Jun2002, Vol. 39 Issue 6, p30 

    Focuses on the standardization for the labels of over-the-counter (OTC) drugs in the U.S. Features of an OTC label described by the U.S. Food and Drugs Administration (FDA); Graphics and formatting specifications to be used for the drug label; Changes in the product packages to meet the design...

  • Labeling changed on Prezista.  // AIDS Alert;Mar2010, Vol. 25 Issue 3, p34 

    The article informs that the Food and Drug Administration (FDA) in the U.S. has approved revisions to the drug darunavir product labeling to include the 96 week data from two clinical trials.

  • Updated Atripla label approved.  // AIDS Alert;Mar2010, Vol. 25 Issue 3, p36 

    The article informs that the Food and Drug Administration (FDA) in the U.S. has approved an updated label for the drug atripla.

  • Etravirine label updated by FDA.  // AIDS Alert;May2010, Vol. 25 Issue 5, p59 

    The article reports on the update of the label for the drug, Etravirine, by the U.S. Food and Drug Administration (FDA).

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;1/1/2003, Vol. 60 Issue 1, p26 

    Provides information on the labeling of pharmaceuticals approved by the U.S. Federal Drug Administration. Description of pharmaceuticals; Usage of pharmaceuticals.

  • FDA to hold public meeting on drug labeling.  // Primary Care Weekly;10/16/95, Vol. 1 Issue 26, p5 

    Reports that the US Food and Drug Administration (FDA) will hold a public meeting on October 30, 1995 to present research on how approved prescription-drug product labeling may be adapted to communicate more effectively to health care providers. Schedule of the meeting; Contact information.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics